TrialThe Lancet. Respiratory medicine2014

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Eitan Kerem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.